Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,330.00
Bid: 2,330.00
Ask: 2,332.00
Change: 26.00 (1.13%)
Spread: 2.00 (0.086%)
Open: 2,305.00
High: 2,331.00
Low: 2,302.00
Prev. Close: 2,304.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Audit Tender

23 Mar 2017 07:00

RNS Number : 2556A
Halma PLC
23 March 2017
 

Trading Update

 

Halma, the leading safety, health and environmental technology group today releases its scheduled Trading Update.

 

Based on current trading and forecasts, the Board expects adjusted profit before tax for the year ending 1 April 2017 to be in line with market consensus (see notes 1 and 2).

 

Halma continues to benefit from the diversity of its markets and resilient growth drivers. Order intake has remained ahead of revenue.

 

Organic constant currency revenue and profit growth has continued in the second half with organic constant currency revenue increases in all major geographic regions. Asia Pacific has maintained a strong performance with good progress in the USA and Mainland Europe. UK revenue has remained steady while there has been improved growth in Other regions, including the Near and Middle East.

 

In the second half, all four sectors have traded in line with the expectations outlined at the half year. The Process Safety sector has achieved revenue and profit growth, benefitting from increased diversification and a modest recovery in certain energy markets. The Environmental & Analysis sector has also made good progress, delivering higher profitability following the Pixelteq reorganisation in the first half. The Infrastructure Safety and Medical sectors have made solid progress, with a stronger contribution from acquisitions completed in 2015/16.

 

We continue to identify potential acquisition opportunities in all four of our sectors. In February 2017, we announced the acquisition of FluxData for an initial consideration of $12 million and an earn-out of up to $15.5 million for growth to March 2019. FluxData, based in New York State, develops multi-spectral imaging solutions for multiple markets including industrial and medical applications and is being successfully integrated into our Environmental & Analysis sector.

 

The Group's financial position remains strong. In November 2016, we increased our Revolving Credit Facility to £550 million from £360 million for five years to 2021. This, together with our continued strong cash flow and the $250m US Private Placement drawn down in January 2016, gives us significant financial resources to achieve our growth objectives.

 

The results for the year ending 1 April 2017 will be released on 13 June 2017.

 

Audit Tender conclusion

 

Halma has concluded an external audit tender process and intends to propose to shareholders, at the 2017 Annual General Meeting, the appointment of PricewaterhouseCoopers LLP as auditor for the accounting year ending 31 March 2018.

 

The decision follows a competitive process undertaken by the Audit Committee, concluding with a recommendation, approved by the Board, to appoint PricewaterhouseCoopers LLP. Further details of the tender process will be included in the Company's Annual Report and Accounts 2017.

 

The current Statutory Auditor, Deloitte LLP, will continue in its role and undertake the audit of Halma plc for the year ending 1 April 2017.

 

 

 

For further information, please contact:

 

Halma plc Tel: +44 (0)1494 721111

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

MHP Communications Tel: +44 (0)20 3128 8100

Rachel Hirst/Andrew Jaques

 

 

Notes:

 

1.

Adjusted profit before tax is before amortisation of acquired intangible assets, acquisition items and profit or loss on disposal of operations and restructuring.

 

2.

The Board believes current market forecasts for adjusted profit before tax to be in the range of £183.7 million to £199.4 million with a consensus of £191.4 million.

 

3.

This Trading Update is based on unaudited management accounts information and has been prepared solely to provide additional information to the shareholders of Halma plc. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

4.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTJTMRTMBATBFR
Date   Source Headline
1st May 20247:00 amRNSAcquisition
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change
30th Nov 20235:28 pmRNSPDMR Shareholding
22nd Nov 20234:36 pmRNSDirector Declaration
20th Nov 20237:00 amRNSAcquisition
16th Nov 20237:00 amRNSHalf Year Results
25th Oct 20237:00 amRNSAcquisitions
3rd Oct 202310:50 amRNSDirector/PDMR Shareholding
27th Sep 202312:28 pmRNSHolding(s) in Company
25th Sep 20231:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSTrading Update
4th Aug 20237:00 amRNSAcquisition
31st Jul 20233:00 pmRNSDirector/PDMR Shareholding
24th Jul 20239:00 amRNSDirectorate Change
20th Jul 20233:51 pmRNSResult of AGM
30th Jun 20239:00 amRNSDirector/PDMR Shareholding
28th Jun 20233:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20233:58 pmRNSAnnual Financial Report
15th Jun 20237:00 amRNSFull Year Results
30th May 20237:11 amRNSDirector Declaration
12th May 20238:00 amRNSCompletion of acquisition
5th May 20237:00 amRNSAcquisition
28th Mar 20237:00 amRNSAcquisition
16th Mar 20237:00 amRNSTrading update
1st Mar 20233:39 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSAcquisition
12th Jan 20237:00 amRNS2022 AGM – Voting Results Update Statement
29th Nov 202212:42 pmRNSDirector/PDMR Shareholding
17th Nov 20227:00 amRNSHalf Year Results
11th Nov 20227:00 amRNSHalma appoints new Chief Financial Officer
6th Oct 20227:00 amRNSAcquisition
3rd Oct 20224:38 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSAcquisition
22nd Sep 20227:00 amRNSTrading Statement
28th Jul 20223:01 pmRNSDirector/PDMR Shareholding
21st Jul 20223:33 pmRNSResult of AGM
4th Jul 20223:38 pmRNSDirector/PDMR Shareholding
29th Jun 20229:54 amRNSDirector/PDMR Shareholding
23rd Jun 20225:50 pmRNSAnnual Financial Report
17th Jun 20224:41 pmRNSDirector/PDMR Shareholding
16th Jun 20227:01 amRNSGroup Chief Executive succession
16th Jun 20227:00 amRNSFinal Results
14th Apr 20227:00 amRNSAcquisition
7th Apr 20227:00 amRNSSite Visit
28th Mar 20221:59 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.